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In spite of the recent interest in the behavioral effects of psycho- 
active drugs, and the practical importance of the data, there has been 
little systematic exploration of drug effects on sensory thresholds 
(UH~, 1961). DICKES, FLAMM, COLTR:EI~A, and To~I~ (1955) report that  
mephenesin, a muscle relaxant, increased threshold of both neutral and 
emotionally charged words presented tachistoscopically. ]~YSENCK and 
AI~A (1957) found a lowering of visual threshold under both dexedrine 
and sodium amytal as compared to a placebo control group. HOLLAND 
and TREADWELL (reported in EYSENCK, 1959) found a general decrease 
in light sensitivity under meprobamate. 
I t  is known clinically tha t  acute dosages of meprobamate occasionally 
produce drowsiness as a side effect, and, therefore, it might be expected 
that  the drug would impair performance on a visual detection task 
demanding sustained attention and accuracy of immediate recall. But  
since the onset and duration of these drug effects have not been demon- 
strated empirically, the present study was concerned primarily with 
tracing out both the time and dosage response curves for meprobamate 
when administered in acute dosages within the therapeutic range. 
Response curves on a visual detection task were ascertained for three 
levels of meprobamate and a placebo at time intervals ranging from 
15 minutes to four hours after ingestion. In order to partially control 
for effects of individual diurnal cycles of activity on performance, the 
experimental sessions were scheduled for both morning and evening 
hours. 
Method 
Sub]ect~. The subjects were 16 male college students, aged 21 and 
over, who were paid for their voluntary participation. Because of 
scheduling difficulties, only 13 of these were also able to participate in 
the morning tests. 
* ~TtIUl~ PLATZ is now &t the VA Central ~P Research Laboratory, Perry 
Point, Maryland and ALFRED B. KRISTOSFn~SO~ at the University of Cincinnati. 
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Apparatus. Visual threshold was measured by using a four-interval, 
temporal forced-choice psychophysical method (BLAc~wELL, 1953). The 
visual target, a circular luminance increment subtending one degree at 
the retina, is superimposed on a large, uniform background of moderate 
luminance. The target  is presented at the fixation point in a location 
known by the subject. Target  exposure duration is 0.010 seconds. 
Each trial is defined by four immediately successive time intervals 
set off by  clearly audible clicks. The interval in which the target  is 
presented is determined at random from trial to trial. After each trial 
the subject indicates his choice by pressing one of four buttons, which 
automatically records his response. Fif ty  successive trials constitute a 
run and require twelve minutes to complete. 
Since the target  is of the same total  energy for all trials, visual 
detection probabilities can be calculated for successive runs. In  order to 
correct for the probabili ty of being correct by  chance 25 % of the time, 
a transformation of the raw score to adjust for chance "hits"  was made 
for the purposes of data  analysis (BLAcKWELL, 1953). 
Testing cycle. Subjects were tested on two mornings, from 8 : 00 a.m. 
to 12:30 p.m., and on four evenings, from 5:00 to 9:30 p.m. Testing 
cycles lasted thi r ty  minutes and were repeated seven times from 5:00 to 
9:30, with a one half hour break for dinner at  7:30, and another half 
hour break at 8:30. A similar schedule was followed for morning tests, 
with lunch and rest breaks at 10:30 and 11:30 a.m. respectively. Sub- 
jects were instructed not to cat for a period of 11/2 hours prior to each 
testing session. The first 15 minutes of each cycle consisted of indi- 
vidually administered psychomotor tests and self-report inventories. 
(These data have been reported separately in U~n, PL•TZ and MILLER, 
1963). The second half of the cycle was used for threshold determination, 
lasting 12 minutes. The seven cycles of threshold determination repre- 
sent an immediate pre-drug test, and test  periods beginning at 1/4 , a/a , 
1 t/a , 18/a, 2 a/a , and 3 a/a hours after ingestion. 
Over a period of two weeks immediately preceding the major experi- 
ment  subjects were given from 8 to 10 hours practice on the detection 
task in order to minimize practice effects, and tested during a complete 
dry run of seven cycles to familiarize them with the complete testing 
procedure. 
Since the testing was carried out in a basement under artificial 
lighting, the illumination during both the visual detection procedure and 
the behavioral testing was the same throughout the testing cycle for both 
morning and evening tests. The visual detection task was run in a 
separate, relatively soundproof room under the low illumination provided 
by the target  screen. 
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Drug dosage and design. During the evening runs a placebo and three 
dosages of meprobamate were used: 400, 800, and 1600 mg. In  all test- 
ings, subjects received four 400 mg capsules, the appropriate propor- 
tion of these being drug capsules and the balance being placebo. Doses 
for the morning runs consisted of 0 and 1600 mg. Within each test- 
ing session the different drug dosages were exactly balanced, and the 
ordering of drugs was balanced across the 16 subjects. Each subject was 
tested six times: four evenings, once under each dosage, and two morn- 
ings, once under placebo and once under 1600 mg of meprobamate. 
One morning session was scheduled at the middle of the four evening 
runs, and the second at the end. The number of subjects who had 
received each of the four dosages during previous evening tests was thus 
balanced for the morning tests. A double-blind administration procedure 
was followed so that  neither subjects nor experimenter knew which 
treatment the subject had received on a specific day. 
Results 
The data were analyzed in three steps: (1) analysis of time and 
dosage effects for the evening tests; (2) analysis of time and drug effects 
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Fig. 1. Visual detection curves under mep]'oba- 
mate and placebo 
for the morning tests; and (3) a 
separate test of interaction between 
drug effects and time of day during 
which subjects were tested. The 
group performance curves showing 
the time and dosage effects of 
meprobamate on visual detection 
threshold are shown in Fig. 1. The 
means and standard deviations 
under each condition are presented 
separately in Table 1. Table 2 
presents the analysis of variance 
related to subject and dosage 
group for the first cycle before the 
drug was administered. Before 
drug ingestion there is no sta- 
tistically significant difference in 
threshold between the four dosage 
groups. The partialling of variance 
due to drug dosage, time elapsed 
after drug administration (cycles 
3--7, from a/4 to 3a/4 hours after 
ingestion), subjects and interactions is presented in Table 3 for the 
evening tests. Both the drug dosage and time period are significant 
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Table 1 
Means and standard deviations /or visual detection under meprobamate and placebo 
Cycle 
Dosage Total  
7 1 I 2 3 4 5 6 
0 510 62 !502 49 474 55 478 56 470 63 472 67 
400 ~92 621481 71 [464160 467154 475172 456 83 
800 503 341474 581469160 461157 464159 440 51 
1600 491 49i48  521461i67 457i84 455i 4 418 
P.M. 499 57 486 59~467 61 466 65 466 68 447 73 
0 477 67 461 74 433 85 437 68 434 74 437 69 
1600 461 58 454 721451168 445 73 443158 434 78 
469 63 73 442 77 441 71 67 436 74 


















beyond the .05 level (using 
the appropriate  interact ions,  
since these were significant,  
as error terms). Inspect ion  
of Fig. 1 indicates tha t  the 
m a x i m u m  effect for the three 
drug dosages occurs on the 
6th cycle, 23/4 hours after 
Table 2. Evening session, cycle 1: Pre-drug test 
Source 4f ~iS F 
Dosage 3 1294.60 0.76 
Subjects . 15 6830.40 4.01" 
Residual . 45 1701.70 
Total 63 
* Significant beyond .01 ]eve] 
drug ingestion, and  short ly after the d inner  break. The response 
curves also show tha t  the a m o u n t  of increase in  threshold is related 
to drug dosage, with subjects showing greatest  increase under  1600 rag, 
least under  400, and  none after the first half  hour  under  placebo. On 
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* Significant beyond .05 level ** Significant beyond .01 level 
the 7th cycle, 33/4 hours after drug adminis t ra t ion ,  the three dosage 
groups show par t ia l  recovery, with the 400 mg group almost  back 
to a pre-drug level. The rate of r e tu rn  to a pre-drug level of perfor- 
mance  appears to be related to drug dosage. The significant  dosage by  
46 
subject interaction indicates marked individual differences in reactivity 
to the drug. The dosage by t ime period interaction is not statistically 
significant. 
Since subjects differ in their response to the drug, one would expect 
tha t  the variance estimate of subject differences should increase as the 
drug takes effect, be maximal  at the point of greatest drug effect, and be 
greater under the drug than  the no drug condition. Table 1 indicates 
this to be partially true for the evening tests. The standard deviation 
for the combined evening tests increases with t ime and is maximal at 
cycle 6, the point at which visual detection was most  affected by the 
drug. Variability was greater under the drug as compared to the no 
drug condition for the 400 mg and 1600 mg runs, but not for the 800 mg 
condition. Interestingly, neither of these effects appears to occur in the 
morning tests where the drug effect was not significant. 
A similar analysis was carried out for the morning runs. On the first, 
or pre-drug cycle, a "t tes t"  to evaluate differences between the means 
of the drug and placebo groups yielded a critical ratio of 1.01, which is 
not statistically significant. The subsequent analysis of variance 
(T~ble 4) showed no significant differences at tr ibutable to either dosage 





Dosage • Time 4 
Dosage • Subjects . . . .  12 
Time • Subjects 48 
Dosage • Time • Subjects 48 
Total 1 
* Significant beyond .05 level. 








(0 vs 1600 rag) or to testing cycle. Individual differences in reaction to 
the drug were significant beyond the .05 level, but  none of the inter- 
actions approached statistical significance. I t  should be noted tha t  the 
drop out of three subjects from the morning tests makes the sample 
somewhat different from the evening group. However, inspection of the 
curves for these three subjects under 0 and 1600 mg during the evening 
tests indicates tha t  they showed essentially the same response effects 
under drug and placebo as did the other 13 subjects. 
In  the light of these contradictory findings an analysis of the variance 
at tr ibutable to morning as compared to evening test  sessions, and 
max imum drug dosage vs. placebo, was run. (Table 5. The scores used 
in the analysis are the sum of the subject 's scores from cycles 3 through 7.) 
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Neither time of day, dosage, nor the inter~.ctions was statistically sig- 
nificant. However, comparison of the two placebo curves showed subjects 
significantly poorer during the morning as compared to the evening 
tests ( t=2.36,  p <  .05). This finding suggests the possibility that  
diurnal metabolic cycles may affect visual threshold either directly or 
indirectly, perhaps by altering the motivational state of the subject. 
If this were the ease, a mildly soporific drug such as meprobamate might 
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well have different effects depending upon the time of administration. 
In the present study a significant decrement in performance after drug 
ingestion was noted for the evening tests when the base line performance 
under placebo was high, but  was not found during the morning tests 
when placebo performance was poor. 
Discussion 
The significant dosage effects for the evening sessions, as well as the 
significant dosage by subject interaction for both morning and evening 
sessions point to a real drug effect on visual detection behavior. How- 
ever, the significant dosage by subject interaction coupled with the lack of 
significance for the morning session also points to one of the erueiM and 
as yet  unsolved problems in the psychological assessment of drug 
aetion: the existence of large individual differences in both sensitivity 
and reactivity to psycho-active drugs (KoRNETSKu and H~r~egntEs, 
1957; KELLY, MrLLEn, MAnq~rIs, GERARD, and UH~, 1958). As yet  little 
work has been done on the selection of populations of subjects who will 
be drug sensitive or drug insensitive, or on the related problem of collect- 
ing normative data on different kinds of reactivity to the same drug. 
A related problem which has not yet  been solved concerns the 
causes of variability within the same individual over time. This effect 
was noted in the discrepancy between the data for the morning and 
evening tests and suggests that  the drug effect is partially dependent 
upon the momentary physiological or psychological state of the subject. 
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I n  this ease, the results m a y  be related to changes in the diurnal meta-  
bolic r h y t h m  from morning to evening. I n  any case one might  expect 
bo th  threshold and the ability to compensate for the effects produced 
by  a mildly soporific drug to va ry  depending upon where in the indi- 
vidual 's  sleep-wake cycle he was tested. 
Summary  
Sixteen male subjects, 21 years  and older, were run in a double- 
blind own-control  design under  three dosages of meprobamate  (400, 
800 and 1600 rag) and matching placebo, to determine response 
curves on a visual detect ion task over a four and one-half hour  period, 
f rom 5:00 to 9 :30  p.m. To control for possible daily cycle effects two 
addit ional runs under  placebo and 1600 mg meprobamate  were con- 
ducted  from 8:00 a.m. to 12:30 p.m. 
The evening tests showed statistically significant dosage effects, t ime 
effects, and a significant drug by  subject interaction. The morning tests 
showed no difference between performance u n d e r  placebo as compared 
to 1600 mg of meprobamate ,  a l though there was a significant drug by  
subject  interaction. This differential drug effect was discussed in terms 
of its possible dependency on the momen ta ry  physiologieM and psycho- 
logical state of the individual and his diurnal metabolic rhy thm.  
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